Donanemab,Aducanumab
eli lilly,Biogen
['aducanumab']
rates of adverse events were similar in the #donanemab and #aducanumab arms, utilized for amyloid plaque and #ad, respectively. #neurotwitter #aanam 
Neurology Advisor provides health care professionals with comprehensive information and clinical news on the management of neurological conditions.